{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:22:58Z","timestamp":1790029378086,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NHLBI SCCOR","award":["P50 HL077100"],"award-info":[{"award-number":["P50 HL077100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-023-03013-7","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T18:01:51Z","timestamp":1703095311000},"page":"487-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Spironolactone improves left atrial function and atrioventricular coupling in patients with resistant hypertension"],"prefix":"10.1007","volume":"40","author":[{"given":"Andrew A.","family":"Girard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Denney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis J.","family":"Dell\u2019Italia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Oparil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg F.","family":"Sharifov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"3013_CR1","doi-asserted-by":"publisher","first-page":"e008731","DOI":"10.1161\/jaha.118.008731","volume":"7","author":"EB Kirkland","year":"2018","unstructured":"Kirkland EB, Heincelman M, Bishu KG et al (2018) Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003\u20132014. J Am Heart Assoc 7:e008731. https:\/\/doi.org\/10.1161\/jaha.118.008731","journal-title":"J Am Heart Assoc"},{"key":"3013_CR2","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS et al (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol 71:e127\u2013e248","journal-title":"J Am Coll Cardiol"},{"key":"3013_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijcard.2021.01.070","volume":"331","author":"G Parati","year":"2021","unstructured":"Parati G, Lombardi C, Pengo M et al (2021) Current challenges for hypertension management: from better hypertension diagnosis to improved patients\u2019 adherence and blood pressure control. Int J Cardiol 331:262\u2013269. https:\/\/doi.org\/10.1016\/j.ijcard.2021.01.070","journal-title":"Int J Cardiol"},{"key":"3013_CR4","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.amjhyper.2005.05.014","volume":"18","author":"SD Pierdomenico","year":"2005","unstructured":"Pierdomenico SD, Lapenna D, Bucci A et al (2005) Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 18:1422\u20131428. https:\/\/doi.org\/10.1016\/j.amjhyper.2005.05.014","journal-title":"Am J Hypertens"},{"key":"3013_CR5","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Calhoun DA, Bakris GL et al (2018) Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension 72:e53\u2013e90. https:\/\/doi.org\/10.1161\/HYP.0000000000000084","journal-title":"Hypertension"},{"key":"3013_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/HJH.0000000000001671","volume":"36","author":"G Bazoukis","year":"2018","unstructured":"Bazoukis G, Thomopoulos, CTsioufis C (2018) Effect of mineralocorticoid antagonists on blood pressure lowering: overview and meta-analysis of randomized controlled trials in hypertension. J Hypertens 36:987\u2013994. https:\/\/doi.org\/10.1097\/HJH.0000000000001671","journal-title":"J Hypertens"},{"key":"3013_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","volume":"49","author":"N Chapman","year":"2007","unstructured":"Chapman N, Dobson J, Wilson S et al (2007) Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 49:839\u2013845. https:\/\/doi.org\/10.1161\/01.HYP.0000259805.18468.8c","journal-title":"Hypertension"},{"key":"3013_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/2047487316675194","volume":"24","author":"SJ Sinnott","year":"2017","unstructured":"Sinnott SJ, Tomlinson LA, Root AA et al (2017) Comparative effectiveness of fourth-line anti-hypertensive agents in resistant hypertension: a systematic review and meta-analysis. Eur J Prev Cardiol 24:228\u2013238. https:\/\/doi.org\/10.1177\/2047487316675194","journal-title":"Eur J Prev Cardiol"},{"key":"3013_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2013.10.055","volume":"63","author":"BD Hoit","year":"2014","unstructured":"Hoit BD (2014) Left atrial size and function: role in prognosis. J Am Coll Cardiol 63:493\u2013505. https:\/\/doi.org\/10.1016\/j.jacc.2013.10.055","journal-title":"J Am Coll Cardiol"},{"key":"3013_CR10","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/ehjci\/jeab266","volume":"23","author":"Z Raisi-Estabragh","year":"2022","unstructured":"Raisi-Estabragh Z, McCracken C, Condurache D et al (2022) Left atrial structure and function are associated with cardiovascular outcomes independent of left ventricular measures: a UK Biobank CMR Study. Eur Heart J Cardiovasc Imaging 23:1191\u20131200. https:\/\/doi.org\/10.1093\/ehjci\/jeab266","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3013_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jacc.2019.11.013","volume":"75","author":"F Bisbal","year":"2020","unstructured":"Bisbal F, Baranchuk A, Braunwald E et al (2020) Atrial failure as a clinical entity: JACC review topic of the week. J Am Coll Cardiol 75:222\u2013232. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.013","journal-title":"J Am Coll Cardiol"},{"key":"3013_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/ehjci\/jeu165","volume":"16","author":"L Sanchis","year":"2015","unstructured":"Sanchis L, Gabrielli L, Andrea R et al (2015) Left atrial dysfunction relates to symptom onset in patients with heart failure and preserved left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging 16:62\u201367. https:\/\/doi.org\/10.1093\/ehjci\/jeu165","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3013_CR13","doi-asserted-by":"publisher","first-page":"e005467","DOI":"10.1161\/CIRCIMAGING.116.005467","volume":"10","author":"M von Roeder","year":"2017","unstructured":"von Roeder M, Rommel KP, Kowallick JT et al (2017) Influence of left atrial function on exercise capacity and left ventricular function in patients with heart failure and preserved ejection fraction. Circ Cardiovasc Imaging. https:\/\/doi.org\/10.1161\/CIRCIMAGING.116.005467","journal-title":"Circ Cardiovasc Imaging"},{"key":"3013_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1161\/CIRCIMAGING.108.819938","volume":"2","author":"S Cheng","year":"2009","unstructured":"Cheng S, Fernandes VR, Bluemke DA et al (2009) Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 2:191\u2013198. https:\/\/doi.org\/10.1161\/CIRCIMAGING.108.819938","journal-title":"Circ Cardiovasc Imaging"},{"key":"3013_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/HYPERTENSIONAHA.111.198028","volume":"61","author":"N Mewton","year":"2013","unstructured":"Mewton N, Opdahl A, Choi EY et al (2013) Left ventricular global function index by magnetic resonance imaging\u2014a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the Multi-Ethnic Study of Atherosclerosis. Hypertension 61:770\u2013778. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.198028","journal-title":"Hypertension"},{"key":"3013_CR16","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1161\/CIRCULATIONAHA.112.112201","volume":"126","author":"J Yeboah","year":"2012","unstructured":"Yeboah J, Rodriguez CJ, Stacey B et al (2012) Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 126:2713\u20132719. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.112201","journal-title":"Circulation"},{"key":"3013_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.amjcard.2007.02.060","volume":"100","author":"T Germans","year":"2007","unstructured":"Germans T, G\u00f6tte MJ, Nijveldt R et al (2007) Effects of aging on left atrioventricular coupling and left ventricular filling assessed using cardiac magnetic resonance imaging in healthy subjects. Am J Cardiol 100:122\u2013127. https:\/\/doi.org\/10.1016\/j.amjcard.2007.02.060","journal-title":"Am J Cardiol"},{"key":"3013_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1161\/HYPERTENSIONAHA.121.17339","volume":"78","author":"T Pezel","year":"2021","unstructured":"Pezel T, Venkatesh BA, De Vasconcellos HD et al (2021) Left atrioventricular coupling index as a prognostic marker of cardiovascular events: the MESA Study. Hypertension 78:661\u2013671. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17339","journal-title":"Hypertension"},{"key":"3013_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 341:709\u2013717. https:\/\/doi.org\/10.1056\/NEJM199909023411001","journal-title":"N Engl J Med"},{"key":"3013_CR20","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1161\/01.cir.102.22.2700","volume":"102","author":"F Zannad","year":"2000","unstructured":"Zannad F, Alla F, Dousset B et al (2000) Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investig Circ 102:2700\u20132706. https:\/\/doi.org\/10.1161\/01.cir.102.22.2700","journal-title":"Rales Investig Circ"},{"key":"3013_CR21","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1161\/HYPERTENSIONAHA.109.141531","volume":"55","author":"K Gaddam","year":"2010","unstructured":"Gaddam K, Corros C, Pimenta E et al (2010) Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study. Hypertension 55:1137\u20131142. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.141531","journal-title":"Hypertension"},{"key":"3013_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1532-429x-11-30","volume":"11","author":"W Feng","year":"2009","unstructured":"Feng W, Nagaraj H, Gupta H et al (2009) A dual propagation contours technique for semi-automated assessment of systolic and diastolic cardiac function by CMR. J Cardiovasc Magn Reson 11:30. https:\/\/doi.org\/10.1186\/1532-429x-11-30","journal-title":"J Cardiovasc Magn Reson"},{"key":"3013_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ehjci\/jey042","volume":"19","author":"LP Badano","year":"2018","unstructured":"Badano LP, Kolias TJ, Muraru D et al (2018) Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 19:591\u2013600. https:\/\/doi.org\/10.1093\/ehjci\/jey042","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3013_CR24","doi-asserted-by":"publisher","first-page":"131102","DOI":"10.1016\/j.ijcard.2023.05.052","volume":"387","author":"O Sharifov","year":"2023","unstructured":"Sharifov O, Denney TS Jr, Girard AA et al (2023) Coronary artery disease is associated with impaired atrial function regardless of left ventricular filling pressure. Int J Cardiol. https:\/\/doi.org\/10.1016\/j.ijcard.2023.05.052","journal-title":"Int J Cardiol"},{"key":"3013_CR25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1081\/jcmr-200036170","volume":"6","author":"B Sievers","year":"2004","unstructured":"Sievers B, Kirchberg S, Addo M et al (2004) Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP. J Cardiovasc Magn Reson 6:855\u2013863. https:\/\/doi.org\/10.1081\/jcmr-200036170","journal-title":"J Cardiovasc Magn Reson"},{"key":"3013_CR26","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jcmg.2011.08.014","volume":"4","author":"W Kosmala","year":"2011","unstructured":"Kosmala W, Przewlocka-Kosmala M, Szczepanik-Osadnik H et al (2011) A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome. JACC Cardiovasc Imaging 4:1239\u20131249. https:\/\/doi.org\/10.1016\/j.jcmg.2011.08.014","journal-title":"JACC Cardiovasc Imaging"},{"key":"3013_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/heartjnl-2018-313182","volume":"105","author":"JP Ferreira","year":"2019","unstructured":"Ferreira JP, Rossignol P, Pizard A et al (2019) Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure. Heart 105:307\u2013314. https:\/\/doi.org\/10.1136\/heartjnl-2018-313182","journal-title":"Heart"},{"key":"3013_CR28","doi-asserted-by":"publisher","first-page":"e019434","DOI":"10.1161\/JAHA.120.019434","volume":"10","author":"SR Aryal","year":"2021","unstructured":"Aryal SR, Siddiqui M, Sharifov OF et al (2021) Spironolactone reduces aortic stiffness in patients with resistant hypertension Independent of blood pressure change. J Am Heart Assoc 10:e019434. https:\/\/doi.org\/10.1161\/JAHA.120.019434","journal-title":"J Am Heart Assoc"},{"key":"3013_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.amjhyper.2004.08.026","volume":"18","author":"J Mahmud, AFeely","year":"2005","unstructured":"Mahmud, AFeely J (2005) Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens 18:50\u201355. https:\/\/doi.org\/10.1016\/j.amjhyper.2004.08.026","journal-title":"Am J Hypertens"},{"key":"3013_CR30","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1161\/01.Cir.0000129307.26791.8e","volume":"109","author":"MK Nishizaka","year":"2004","unstructured":"Nishizaka MK, Zaman MA, Green SA et al (2004) Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation 109:2857\u20132861. https:\/\/doi.org\/10.1161\/01.Cir.0000129307.26791.8e","journal-title":"Circulation"},{"key":"3013_CR31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/01.Cir.0000138680.89536.A9","volume":"110","author":"PM Mottram","year":"2004","unstructured":"Mottram PM, Haluska B, Leano R et al (2004) Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 110:558\u2013565. https:\/\/doi.org\/10.1161\/01.Cir.0000138680.89536.A9","journal-title":"Circulation"},{"key":"3013_CR32","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1093\/eurheartj\/ehi478","volume":"26","author":"P Milliez","year":"2005","unstructured":"Milliez P, Deangelis N, Rucker-Martin C et al (2005) Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. Eur Heart J 26:2193\u20132199. https:\/\/doi.org\/10.1093\/eurheartj\/ehi478","journal-title":"Eur Heart J"},{"key":"3013_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00029330-200801010-00008","volume":"121","author":"SS Yang","year":"2008","unstructured":"Yang SS, Han W, Zhou HY et al (2008) Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs. Chin Med J (Engl) 121:38\u201342","journal-title":"Chin Med J (Engl)"},{"key":"3013_CR34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/ehjci\/jev083","volume":"16","author":"L Caballero","year":"2015","unstructured":"Caballero L, Kou S, Dulgheru R et al (2015) Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study. Eur Heart J Cardiovasc Imaging 16:1031\u20131041. https:\/\/doi.org\/10.1093\/ehjci\/jev083","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3013_CR35","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/s0002-9149(02)02864-3","volume":"90","author":"TS Tsang","year":"2002","unstructured":"Tsang TS, Barnes ME, Gersh BJ et al (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90:1284\u20131289. https:\/\/doi.org\/10.1016\/s0002-9149(02)02864-3","journal-title":"Am J Cardiol"},{"key":"3013_CR36","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1161\/01.CIR.0000066318.21784.43","volume":"107","author":"JE Moller","year":"2003","unstructured":"Moller JE, Hillis GS, Oh JK et al (2003) Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation 107:2207\u20132212. https:\/\/doi.org\/10.1161\/01.CIR.0000066318.21784.43","journal-title":"Circulation"},{"key":"3013_CR37","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ejechocard\/jen235","volume":"10","author":"K Fatema","year":"2009","unstructured":"Fatema K, Barnes ME, Bailey KR et al (2009) Minimum vs. maximum left atrial volume for prediction of first atrial fibrillation or flutter in an elderly cohort: a prospective study. Eur J Echocardiogr 10:282\u2013286. https:\/\/doi.org\/10.1093\/ejechocard\/jen235","journal-title":"Eur J Echocardiogr"},{"key":"3013_CR38","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/0735-1097(93)90787-2","volume":"22","author":"CP Appleton","year":"1993","unstructured":"Appleton CP, Galloway JM, Gonzalez MS et al (1993) Estimation of left ventricular filling pressures using two-dimensional and doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. J Am Coll Cardiol 22:1972\u20131982. https:\/\/doi.org\/10.1016\/0735-1097(93)90787-2","journal-title":"J Am Coll Cardiol"},{"key":"3013_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1532-429X-15-99","volume":"15","author":"K Posina","year":"2013","unstructured":"Posina K, McLaughlin J, Rhee P et al (2013) Relationship of phasic left atrial volume and emptying function to left ventricular filling pressure: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 15:99. https:\/\/doi.org\/10.1186\/1532-429X-15-99","journal-title":"J Cardiovasc Magn Reson"},{"key":"3013_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1532-429X-13-42","volume":"13","author":"M Kaminski","year":"2011","unstructured":"Kaminski M, Steel K, Jerosch-Herold M et al (2011) Strong cardiovascular prognostic implication of quantitative left atrial contractile function assessed by cardiac magnetic resonance imaging in patients with chronic hypertension. J Cardiovasc Magn Reson 13:42. https:\/\/doi.org\/10.1186\/1532-429X-13-42","journal-title":"J Cardiovasc Magn Reson"},{"key":"3013_CR41","doi-asserted-by":"publisher","first-page":"e026875","DOI":"10.1161\/JAHA.122.026875","volume":"11","author":"MP Huber","year":"2022","unstructured":"Huber MP, Pandit JA, Jensen PN et al (2022) Left atrial strain and the risk of atrial arrhythmias from extended ambulatory cardiac monitoring: MESA. J Am Heart Assoc 11:e026875. https:\/\/doi.org\/10.1161\/JAHA.122.026875","journal-title":"J Am Heart Assoc"},{"key":"3013_CR42","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/jama.2013.905","volume":"309","author":"F Edelmann","year":"2013","unstructured":"Edelmann F, Wachter R, Schmidt AG et al (2013) Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. J Am Med Assoc 309:781\u2013791. https:\/\/doi.org\/10.1001\/jama.2013.905","journal-title":"J Am Med Assoc"},{"key":"3013_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/jhh.2014.83","volume":"29","author":"A Gupta","year":"2015","unstructured":"Gupta A, Schiros CG, Gaddam KK et al (2015) Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy. J Hum Hypertens 29:241\u2013246. https:\/\/doi.org\/10.1038\/jhh.2014.83","journal-title":"J Hum Hypertens"},{"key":"3013_CR44","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1007\/s10554-021-02324-x","volume":"37","author":"S Unlu","year":"2021","unstructured":"Unlu S, Yamak BA, Sezenoz B et al (2021) Left atrial contractile longitudinal strain determines intrinsic left atrial function regardless of load status and left ventricular deformation. Int J Cardiovasc Imaging 37:3245\u20133253. https:\/\/doi.org\/10.1007\/s10554-021-02324-x","journal-title":"Int J Cardiovasc Imaging"},{"key":"3013_CR45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/ejhf.1060","volume":"20","author":"S Selvaraj","year":"2018","unstructured":"Selvaraj S, Claggett B, Shah SJ et al (2018) Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial. Eur J Heart Fail 20:483\u2013490. https:\/\/doi.org\/10.1002\/ejhf.1060","journal-title":"Eur J Heart Fail"},{"key":"3013_CR46","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","volume":"8","author":"JB Cohen","year":"2020","unstructured":"Cohen JB, Schrauben SJ, Zhao L et al (2020) Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone. JACC Heart Fail 8:172\u2013184","journal-title":"JACC Heart Fail"},{"key":"3013_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ajh\/hpu150","volume":"28","author":"P Dobrowolski","year":"2015","unstructured":"Dobrowolski P, Klisiewicz A, Prejbisz A et al (2015) Factors associated with diastolic dysfunction in patients with resistant hypertension: resist-POL study. Am J Hypertens 28:307\u2013311. https:\/\/doi.org\/10.1093\/ajh\/hpu150","journal-title":"Am J Hypertens"},{"key":"3013_CR48","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/eurheartj\/ehu093","volume":"35","author":"F Mahfoud","year":"2014","unstructured":"Mahfoud F, Urban D, Teller D et al (2014) Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J 35:2224\u20132231. https:\/\/doi.org\/10.1093\/eurheartj\/ehu093","journal-title":"Eur Heart J"},{"key":"3013_CR49","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/10641963.2017.1291663","volume":"39","author":"A Ye\u015filtepe","year":"2017","unstructured":"Ye\u015filtepe A, Dizdar OS, Gorkem H et al (2017) Maintenance of negative fluid balance can improve endothelial and cardiac functions in primary hypertensive patients. Clin Exp Hypertens 39:579\u2013586. https:\/\/doi.org\/10.1080\/10641963.2017.1291663","journal-title":"Clin Exp Hypertens"},{"key":"3013_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.22956","author":"AA Sahin","year":"2020","unstructured":"Sahin AA, Ozben B, Sunbul M et al (2020) The effect of cardiac rehabilitation on blood pressure, and on left atrial and ventricular functions in hypertensive patients. J Clin Ultrasound. https:\/\/doi.org\/10.1002\/jcu.22956","journal-title":"J Clin Ultrasound"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-03013-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-023-03013-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-03013-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T12:36:25Z","timestamp":1710851785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-023-03013-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["3013"],"URL":"https:\/\/doi.org\/10.1007\/s10554-023-03013-7","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"27 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by NHLBI SCCOR P50 HL077100. The funding organization did not have any role in the design and conduct of the study; data collection and analysis, or interpretation of findings. In relation to this work, Dr. Oparil is the Editor-in-Chief, Current Hypertension Reports (Journal; Publisher \u2013 Springer Science Business Media LLC); with annual stipend from Springer. Other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}